196 related articles for article (PubMed ID: 33825709)
1. Crystal structures of β-1,4-N-acetylglucosaminyltransferase 2: structural basis for inherited muscular dystrophies.
Yang JY; Halmo SM; Praissman J; Chapla D; Singh D; Wells L; Moremen KW; Lanzilotta WN
Acta Crystallogr D Struct Biol; 2021 Apr; 77(Pt 4):486-495. PubMed ID: 33825709
[TBL] [Abstract][Full Text] [Related]
2. Protein
Halmo SM; Singh D; Patel S; Wang S; Edlin M; Boons GJ; Moremen KW; Live D; Wells L
J Biol Chem; 2017 Feb; 292(6):2101-2109. PubMed ID: 27932460
[TBL] [Abstract][Full Text] [Related]
3. The structure of POMGNT2 provides new insights into the mechanism to determine the functional O-mannosylation site on α-dystroglycan.
Imae R; Kuwabara N; Manya H; Tanaka T; Tsuyuguchi M; Mizuno M; Endo T; Kato R
Genes Cells; 2021 Jul; 26(7):485-494. PubMed ID: 33893702
[TBL] [Abstract][Full Text] [Related]
4. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
[TBL] [Abstract][Full Text] [Related]
5. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
6. GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody.
Ogawa M; Nakamura N; Nakayama Y; Kurosaka A; Manya H; Kanagawa M; Endo T; Furukawa K; Okajima T
Biochem Biophys Res Commun; 2013 Oct; 440(1):88-93. PubMed ID: 24041696
[TBL] [Abstract][Full Text] [Related]
7. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
[TBL] [Abstract][Full Text] [Related]
8. The role of defective glycosylation in congenital muscular dystrophy.
Schachter H; Vajsar J; Zhang W
Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
[TBL] [Abstract][Full Text] [Related]
9. Recent advancements in understanding mammalian O-mannosylation.
Sheikh MO; Halmo SM; Wells L
Glycobiology; 2017 Sep; 27(9):806-819. PubMed ID: 28810660
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.
Martin PT
Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553
[TBL] [Abstract][Full Text] [Related]
11. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
Martin-Rendon E; Blake DJ
Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
[TBL] [Abstract][Full Text] [Related]
12. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan.
Praissman JL; Live DH; Wang S; Ramiah A; Chinoy ZS; Boons GJ; Moremen KW; Wells L
Elife; 2014 Oct; 3():. PubMed ID: 25279697
[TBL] [Abstract][Full Text] [Related]
13. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
[TBL] [Abstract][Full Text] [Related]
14. Mammalian
Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
[TBL] [Abstract][Full Text] [Related]
15. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
Balci-Hayta B; Talim B; Kale G; Dincer P
BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
[TBL] [Abstract][Full Text] [Related]
16. Journey into muscular dystrophies caused by abnormal glycosylation.
Muntoni F
Acta Myol; 2004 Sep; 23(2):79-84. PubMed ID: 15605948
[TBL] [Abstract][Full Text] [Related]
17. Muscular dystrophies due to defective glycosylation of dystroglycan.
Muntoni F; Brockington M; Godfrey C; Ackroyd M; Robb S; Manzur A; Kinali M; Mercuri E; Kaluarachchi M; Feng L; Jimenez-Mallebrera C; Clement E; Torelli S; Sewry CA; Brown SC
Acta Myol; 2007 Dec; 26(3):129-35. PubMed ID: 18646561
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
19. Zebrafish models for human FKRP muscular dystrophies.
Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
[TBL] [Abstract][Full Text] [Related]
20. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.
Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H
Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
